256 related articles for article (PubMed ID: 29432441)
21. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
22. FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances.
Zhao H; Chen W; Du P; Sun A; Zhuang C; Tong J; Wang L
Tumour Biol; 2015 Jun; 36(6):4319-26. PubMed ID: 25596086
[TBL] [Abstract][Full Text] [Related]
23. Association between the FAS/FASL polymorphisms and gastric cancer risk: a meta-analysis.
Tian J; Pan F; Li J; Ma Y; Cen H; Pan HF; Pan YY; Ye DQ
Asian Pac J Cancer Prev; 2012; 13(3):945-51. PubMed ID: 22631677
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.
Daripally S; Nallapalle SR; Katta S; Prasad VV
Tumour Biol; 2015 Sep; 36(10):7817-30. PubMed ID: 25944167
[TBL] [Abstract][Full Text] [Related]
25. Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.
Yıldır S; Sezgin M; Barlas IÖ; Türköz G; Ankaralı HÇ; Şahin G; Erdal ME
Rheumatol Int; 2013 Oct; 33(10):2637-45. PubMed ID: 23749041
[TBL] [Abstract][Full Text] [Related]
26. Anti-GM1 IgG antibodies in Guillain-Barré syndrome: fine specificity is associated with disease severity.
Lardone RD; Yuki N; Odaka M; Daniotti JL; Irazoqui FJ; Nores GA
J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):629-33. PubMed ID: 19965859
[TBL] [Abstract][Full Text] [Related]
27. Clinical and serological prognostic factors in childhood Guillain-Barré syndrome: A prospective cohort study in Bangladesh.
Hasan I; Papri N; Hayat S; Jahan I; Ara G; Islam B; Islam Z
J Peripher Nerv Syst; 2021 Mar; 26(1):83-89. PubMed ID: 33555098
[TBL] [Abstract][Full Text] [Related]
28. Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.
Wang Z; Gu J; Nie W; Xu J; Huang G; Guan X
Tumour Biol; 2014 Apr; 35(4):3035-9. PubMed ID: 24248546
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor-alpha polymorphisms and expression in Guillain-Barré syndrome.
Prasad KN; Nyati KK; Verma A; Rizwan A; Paliwal VK
Hum Immunol; 2010 Sep; 71(9):905-10. PubMed ID: 20600447
[TBL] [Abstract][Full Text] [Related]
30. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
[TBL] [Abstract][Full Text] [Related]
31. Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study.
Sekiguchi Y; Uncini A; Yuki N; Misawa S; Notturno F; Nasu S; Kanai K; Noto Y; Fujimaki Y; Shibuya K; Ohmori S; Sato Y; Kuwabara S
J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):23-8. PubMed ID: 22010183
[TBL] [Abstract][Full Text] [Related]
32. Human leukocyte antigen-DQB1 polymorphisms and haplotype patterns in Guillain-Barré syndrome.
Hayat S; Jahan I; Das A; Hassan Z; Howlader ZH; Mahmud I; Deen Mohammad Q; Islam Z
Ann Clin Transl Neurol; 2019 Sep; 6(9):1849-1857. PubMed ID: 31469245
[TBL] [Abstract][Full Text] [Related]
33. The diplotype Fas -1377A/-670G as a genetic marker to predict a lower risk of breast cancer in Chinese women.
Xu Y; Deng Q; He B; Pan Y; Li R; Gao T; Sun H; Song G; Wang S; Cho WC
Tumour Biol; 2014 Sep; 35(9):9147-61. PubMed ID: 24916571
[TBL] [Abstract][Full Text] [Related]
34. Gene Polymorphisms of Interleukin-27 Correlate with the Susceptibility, Severity, and Clinical Outcomes of Elderly People with Guillain-Barré Syndrome.
Zhang H; Zhao H; Yang G; Li Y; Liu Y
Gerontology; 2022; 68(8):854-860. PubMed ID: 34607327
[TBL] [Abstract][Full Text] [Related]
35. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh.
Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP
Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160
[TBL] [Abstract][Full Text] [Related]
36. Nucleotide oligomerization domain polymorphism confers no risk to Guillain-Barré syndrome.
Hayat S; Asad A; Hasan I; Jahan I; Papri N; Howlader ZH; Islam Z
Acta Neurol Scand; 2022 Aug; 146(2):177-185. PubMed ID: 35652365
[TBL] [Abstract][Full Text] [Related]
37. No association between FCGR2A and FCGR3A polymorphisms in Guillain-Barré Syndrome in a Brazilian population.
Dourado ME; Ferreira LC; Freire-Neto FP; Jeronimo SM
J Neuroimmunol; 2016 Sep; 298():160-4. PubMed ID: 27609290
[TBL] [Abstract][Full Text] [Related]
38. Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barré syndrome.
Csurhes PA; Sullivan AA; Green K; Greer JM; Pender MP; McCombe PA
J Clin Neurosci; 2005 May; 12(4):409-15. PubMed ID: 15925771
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain-Barré syndrome.
Kharwar NK; Prasad KN; Singh K; Paliwal VK; Modi DR
Int J Neurosci; 2017 Aug; 127(8):680-687. PubMed ID: 27595159
[TBL] [Abstract][Full Text] [Related]
40. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
